Daniel Wolle

Daniel Wolle Ph.D. began their work experience as a Research Assistant at Nemours- A.I Dupont Hospital for Children from June 2007 to August 2009. Daniel then pursued their Ph.D. in Molecular Biology at Princeton University from 2009 to 2015, where they also served as a Graduate Teaching Assistant. After that, they worked as a Contract Writer at LifeSci Capital in October and November 2014. Following this, they joined Piper Jaffray as an Equity Research Analyst from January 2016 to May 2018, focusing on healthcare equity research. Subsequently, Daniel Wolle transitioned to J.P. Morgan, initially as an Associate in Equity Research from June 2018 to January 2021, advancing to Vice President in Equity Research from January 2021 to March 2023. Currently, they hold the position of Principal at JEITO since April 2023.

Daniel Wolle Ph.D. holds a Bachelor of Science (BS) degree in Biochemistry from UCLA, obtained between 2003 and 2005. Daniel then pursued a Doctor of Philosophy (Ph.D.) in Molecular Biology at Princeton University from 2009 to 2015. Additionally, they obtained certifications in "Introduction to Data and Probability" from Duke University Continuing Studies in 2015 and in "Series 7, 63, 86, 87" from the Financial Industry Regulatory Authority (FINRA).